The company had posted overall sales revenue of Rs 899 crore in 2014-15 fiscal, said Fujifilm India in a statement.
During the fiscal, the company had launched various new products in the Indian market including its Instax range of instant cameras.
In medical systems, the company had introduced Amulet Innovality, a highly advanced breast cancer diagnostic machine enabling early detection of breast cancer with its 50 Micron 3D image quality, and advanced tomosynthesis technology.
The company had installed Amulet Innovality in many top private and government hospitals in India and is promoting the importance of early detection.
On the outlook, Nishiyama said: "I am confident that we will continue to grow and dominate an even larger share in the respective divisions. We are very excited on our India journey and look forward to achieve 20 per cent growth in FY 2016-17."
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Access to Exclusive Premium Stories
Over 30 subscriber-only stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app